Base Year
Historical Year
Forecast Year
The global bronchiectasis drugs market size is projected to expand by USD 126.75 million between 2021 and 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Conventional techniques used to diagnose bacterial lung infection have several constraints, including failure to accurately identify the cause of infection and failure to provide a full representation of the bacterial load present in the lungs, thus, leading to the development of advanced technologies like high-resolution computed tomography (HRCT) scan, aiding the bronchiectasis drugs market. Further, the availability of low-cost drugs is one of the major factors aiding the bronchiectasis drugs industry, globally.
Bronchiectasis can lead to a build-up of excess mucous, making the lungs more vulnerable to infection. The major method to treat bronchiectasis remains the use of antibiotics to avoid infection.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be broadly categorised on the basis of its product into:
The EMR report looks into the regional bronchiectasis drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The high-resolution computed tomography (HRCT) scan has emerged as popular technique to diagnose bronchiectasis and other respiratory diseases. Such developments in respiratory disease diagnostics will allow pulmonologists and otolaryngologists to accurately define the disease phase and provide patients with suitable and timely therapy and medicines. This trend will have a positive effect over the forecast period on bronchiectasis drugs market growth. Further, the accessibility to low-cost and off-label generic drugs is one of the major factors responsible for the development of the market. Generic drug contains the same active pharmaceutical ingredient (API) as branded drugs and are less expensive than branded drugs. The availability of such low-priced drugs, combined with rising bronchiectasis incidence, will increase therapeutic adoption rates, particularly in underdeveloped and developing countries. The approval of these low-cost generics will further increase the growth opportunities for market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global bronchiectasis drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global bronchiectasis drugs market is projected to grow by USD 126.75 million between 2021 and 2026.
The major drivers of the market include the development of innovative technologies to diagnose bacterial lung infection and the growing pharmaceutical sector.
The availability of low-cost drugs and the increasing accessibility of generic drugs are key trends propelling the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading products in the market are antibiotics, expectorants, and other drugs.
The major players in the market are GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc., and Reckitt Benckiser Group Plc, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share